TY - JOUR
T1 - Breast Cancer, Secondary Breast Cancers in Childhood Cancer Male Survivors—Characteristics and Risks
AU - Demoor-Goldschmidt, Charlotte
AU - Allodji, Rodrigue S.
AU - Jackson, Angela
AU - Vu-Bezin, Giao
AU - Souchard, Vincent
AU - Fresneau, Brice
AU - le Fayech, Chiraz
AU - Haddy, Nadia
AU - Rubino, Carole
AU - Pacquement, Helène
AU - Veres, Cristina
AU - Llanas, Damien
AU - Diallo, Ibrahima
AU - de Vathaire, Florent
N1 - Publisher Copyright:
© 2018 Elsevier Inc.
PY - 2018/11/1
Y1 - 2018/11/1
N2 - Purpose: Male breast cancer (MBC) is uncommon, accounting for less than 1% of all breast cancers. Secondary breast cancers among childhood cancer survivors have been well described in the literature, but less is known about MBC. Methods and Materials: We carried out an analysis in a cohort of 7019 five-year survivors of a solid childhood (aged ≤20 years) cancer treated in France before 2001 and followed for an average of 20 years and compared breast cancers occurring in both men and women. Results: Among the 7019 survivors, 4 out of 3893 male survivors developed breast cancer, compared with 99 out of 3126 female survivors. All of the men had a history of radiation therapy. The 4 men with MBC had estrogen receptors and 3 had progesterone receptors. Conclusions: MBC is a rare second malignancy among childhood cancer survivors. Receipt of radiation therapy is a recognized risk factor, but more data about eventual genetic mutations are necessary. Regular screening based only on a history of radiation therapy is not recommended; however, attention must be given in the case of suspicious symptoms.
AB - Purpose: Male breast cancer (MBC) is uncommon, accounting for less than 1% of all breast cancers. Secondary breast cancers among childhood cancer survivors have been well described in the literature, but less is known about MBC. Methods and Materials: We carried out an analysis in a cohort of 7019 five-year survivors of a solid childhood (aged ≤20 years) cancer treated in France before 2001 and followed for an average of 20 years and compared breast cancers occurring in both men and women. Results: Among the 7019 survivors, 4 out of 3893 male survivors developed breast cancer, compared with 99 out of 3126 female survivors. All of the men had a history of radiation therapy. The 4 men with MBC had estrogen receptors and 3 had progesterone receptors. Conclusions: MBC is a rare second malignancy among childhood cancer survivors. Receipt of radiation therapy is a recognized risk factor, but more data about eventual genetic mutations are necessary. Regular screening based only on a history of radiation therapy is not recommended; however, attention must be given in the case of suspicious symptoms.
UR - http://www.scopus.com/inward/record.url?scp=85053181091&partnerID=8YFLogxK
U2 - 10.1016/j.ijrobp.2018.07.2017
DO - 10.1016/j.ijrobp.2018.07.2017
M3 - Article
C2 - 30096470
AN - SCOPUS:85053181091
SN - 0360-3016
VL - 102
SP - 578
EP - 583
JO - International Journal of Radiation Oncology Biology Physics
JF - International Journal of Radiation Oncology Biology Physics
IS - 3
ER -